Health Canada approved Pediapharm Inc.'s Otixal for the treatment of acute otitis media with tympanostomy tubes in pediatric patients.
Otixal is an antibiotic and steroid combination ear drop.
Health Canada approves Pediapharm ear infection drug
Gauging Supply Chain Risk In Volatile Times
Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals
The Future of Risk Management Digitization in Credit Risk Management
Climate Credit Analytics: Diving into the model
Health Canada approves Pediapharm ear infection drug
- Author Mirza Salam Ahmed
- Theme Healthcare & Pharmaceuticals